Submissions from 2015
Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders, Y. Chung, A. Jacobson, G. He, T. G. van Erp, S. McEwen, J. Addington, C. E. Bearden, K. Cadenhead, B. A. Cornblatt, T. D. Cannon, and +8 additional authors
Abnormal movements in first-episode, nonaffective psychosis: Dyskinesias, stereotypies, and catatonic-like signs, M. T. Compton, F. Fantes, C. R. Wan, S. Johnson, and E. F. Walker
Antipsychotic Use in Youth Without Psychosis A Double-edged Sword, C. U. Correll and J. C. Blader
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder, C. U. Correll, J. Detraux, J. De Lepeleire, and M. De Hert
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial, C. U. Correll, A. Skuban, J. Ouyang, M. Hobart, S. Pfister, R. D. McQuade, M. Nyilas, W. H. Carson, R. Sanchez, and H. Eriksson
Early intervention services in psychosis: from evidence to wide implementation, C. Csillag, M. Nordentoft, M. Mizuno, P. B. Jones, E. Killackey, M. Taylor, E. Chen, J. M. Kane, and D. McDaid
Attitudes of Psychiatric Nurses about the Request for Euthanasia on the Basis of Unbearable Mental Suffering(UMS), M. De Hert, L. Van Bos, K. Sweers, M. Wampers, J. De Lepeleire, and C. U. Correll
Young-Onset Dementia Epidemiology Applied to Neuropsychiatry Practice, B. Devineni and C. U. Onyike
Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia, R. Emsley, L. Asmal, B. Chiliza, S. du Plessis, J. Carr, M. Kidd, A. K. Malhotra, M. Vink, and R. S. Kahn
Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study, R. L. Findling, A. Robb, N. K. McNamara, M. N. Pavuluri, V. Kafantaris, R. Scheffer, J. A. Frazier, M. Rynn, M. DelBello, R. A. Kowatch, B. M. Rowles, J. Lingler, K. Martz, R. Anand, T. E. Clemons, and P. Taylor-Zapata
Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder, E. B. Foa; H. B. Simpson; D. Rosenfield; M. R. Liebowitz; S. P. Cahill; J. D. Huppert; J., Jr. Bender; C. P. McLean; M. J. Maher; R. Campeas; C. G. Hahn; P. Imms; A. Pinto; M. B. Powers; C. I. Rodriguez; P. E. Van Meter; D. Vermes; and M. T. Williams
Predictors of suicide attempts in 3.322 patients with affective disorders and schizophrenia spectrum disorders, J. A. Gallego, V. Rachamallu, E. Y. Yuen, S. Fink, L. M. Duque, and J. M. Kane
Do antipsychotics increase diabetes risk in children and adolescents?, B. Galling and C. U. Correll
Genome-wide association study of schizophrenia in Ashkenazi Jews, F. S. Goes, J. McGrath, E. E. Kenny, V. Vacic, I. Peters, T. Lencz, A. Darvasi, J. G. Mulle, S. T. Warren, A. E. Pulver, and +5 additional authors
THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS, J. F. Goldberg, M. P. Freeman, R. Balon, L. Citrome, M. E. Thase, J. M. Kane, and M. Fava
Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials, T. E. Goldberg, P. D. Harvey, K. A. Wesnes, P. J. Snyder, and L. S. Schneider
How Can Community Religious Groups Aid Recovery for Individuals with Psychotic Illnesses?, J. L. Griffith, N. Myers, and M. T. Compton
Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case-Control Study, H. M. Guo, M. Liu, Y. T. Xiang, J. Zhao, G. S. Ungvari, C. U. Correll, C. H. Ng, H. F. Chiu, and Z. P. Duan
Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters, T. Guo, Y. T. Xiang, L. Xiao, C. Q. Hu, H. F. Chiu, G. S. Ungvari, C. U. Correll, K. Y. Lai, L. Feng, Y. Geng, Y. Feng, and G. Wang
Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance, P. M. Haddad, T. Kishimoto, C. U. Correll, and J. M. Kane
Memory systems in schizophrenia: Modularity is preserved but deficits are generalized, K. M. Haut, K. H. Karlsgodt, R. M. Bilder, E. Congdon, N. B. Freimer, E. D. London, F. W. Sabb, J. Ventura, and T. D. Cannon
Reading Between the Lines: Finding Fundamental Themes in Fiction, P. Hoffman, K. Fiore, and R. Dicker
Genome-wide autozygosity is associated with lower general cognitive ability, D. P. Howrigan, M. A. Simonson, G. Davies, S. E. Harris, A. Tenesa, J. M. Starr, D. C. Liewald, D. I. Boomsma, P. DeRosse, M. C. Keller, and +37 additional authors
Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients, P. Ifteni, E. Grudnikoff, J. Koppel, Neil Kremen, C. U. Correll, J. M. Kane, and Peter Manu
Subcortical modulation in auditory processing and auditory hallucinations, T. Ikuta, P. DeRosse, M. Argyelan, K. H. Karlsgodt, P. B. Kingsley, P. R. Szeszko, and A. K. Malhotra
Corrected QT Changes During Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials, K. G. Jensen, K. Juul, A. Fink-Jensen, C. U. Correll, and A. K. Pagsberg
Oxidative Stress and Antioxidant Parameters in Patients With Major Depressive Disorder Compared to Healthy Controls Before and After Antidepressant Treatment: Results From a Meta-Analysis, S. Jimenez-Fernandez, M. Gurpegui, F. Diaz-Atienza, L. Perez-Costillas, M. Gerstenberg, and C. U. Correll
Schizophrenia, R. S. Kahn, I. E. Sommer, R. M. Murray, A. Meyer-Lindenberg, D. R. Weinberger, T. D. Cannon, M. O'Donovan, C. U. Correll, J. M. Kane, T. R. Insel, and +1 additional author
The role of NMDA receptors in schizophrenia, J. M. Kane
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia, J. M. Kane, A. Skuban, J. Ouyang, M. Hobart, S. Pfister, R. D. McQuade, M. Nyilas, W. H. Carson, R. Sanchez, and H. Eriksson
Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial, J. M. Kane, S. Zukin, Y. Wang, K. Lu, A. Ruth, K. Nagy, I. Laszlovszky, and S. Durgam
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial, J. T. Kantrowitz, S. W. Woods, E. Petkova, B. A. Cornblatt, C. M. Corcoran, H. Chen, G. Silipo, and D. C. Javitt
More data on speed of remission with ECT in geriatric depression, C. H. Kellner, E. T. Geduldig, R. D. Weiner, R. M. Greenberg, J. Prudic, W. V. McCall, G. Petrides, M. M. Husain, M. V. Rudorfer, S. H. Lisanby, and +2 additional authors
Adapting the Crisis Intervention Team (CIT) Model of Police-Mental Health Collaboration in a Low-Income, Post-Conflict Country: Curriculum Development in Liberia, West Africa, B. A. Kohrt, E. Blasingame, M. T. Compton, S. F. Dakana, B. Dossen, F. Lang, P. Strode, and J. Cooper
[Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Pro], M. Lambert and C. U. Correll
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis, S. H. Lee, T. Lencz, A. K. Malhotra, H. Medeiros, V. Milanova, J. Shi, P. Sklar, P. K. Gregersen, M. van Laar, P. van Riel, and +134 additional authors
Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic, T. Lencz and A. K. Malhotra
Services on early recognition of psychoses and bipolar disorders in Germany, K. Leopold, A. Nikolaides, M. Bauer, A. Bechdolf, C. U. Correll, F. Jessen, J. Klosterkotter, S. Ruhrmann, S. Pfeiffer, A. Pfennig, and +3 additional authors
ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial, J. A. Lieberman, R. E. Davis, C. U. Correll, D. C. Goff, J. M. Kane, C. A. Tamminga, S. Mates, and K. E. Vanover
Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: Findings of the third national survey on use of psychotropic medications in China, Q. Li, Y. T. Xiang, Y. A. Su, L. Shu, X. Yu, H. F. Chiu, Christoph Correll, G. S. Ungvari, K. Y. Lai, T. M. Si, and +9 additional authors
Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012), Q. Li, Y. T. Xiang, Y. A. Su, L. Shu, X. Yu, C. U. Correll, Q. Y. Mei, K. Q. Li, T. M. Si, J. M. Kane, and +9 additional authors
Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients, S. W. Liu, Y. L. Liu, L. L. Hwang, S. L. Wu, Y. W. Dai, S. C. Liu, I. K. Ho, A. C. Chen, C. F. Hsiao, H. H. Tsou, and +2 additional authors
Common variants of IRF3 conferring risk of schizophrenia, X. Li, W. Zhang, T. Lencz, A. Darvasi, A. Alkelai, D. F. Zhang, L. Yu, X. F. Xu, M. Li, Y. G. Yao, and +2 additional authors
Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation, A. Loebel, L. Citrome, C. U. Correll, J. Xu, J. Cucchiaro, and J. M. Kane
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis, C. Luchini, N. Veronese, M. Solmi, H. Cho, J. H. Kim, S. Kyo, S. Y. Lee, D. W. Kim, G. M. Yousef, C. U. Correll, and +22 additional authors
Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder, R. Maier, G. Moser, C. M. Hultman, M. Landen, D. F. Levinson, K. S. Kendler, J. W. Smoller, N. R. Wray, S. H. Lee, T. Lencz, and +7 additional authors
Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia, A. K. Malhotra
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management, P. Manu, L. Dima, M. Shulman, D. Vancampfort, M. De Hert, and C. U. Correll
Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?, X. R. Ma, Y. Q. Lin, Y. Li, H. F. K. Chiu, G. S. Ungvari, C. U. Correll, K. Y. C. Lai, M. Y. Cai, J. Yun, Y. T. Xiang, and +5 additional authors
Anxiety in youth at clinical high risk for psychosis, L. McAusland, L. Buchy, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, E. F. Walker, S. W. Woods, C. E. Bearden, D. H. Mathalon, J. Addington, and +5 additional authors
Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial, W. R. McFarlane, B. Levin, L. Travis, F. L. Lucas, S. Lynch, M. Verdi, Barbara Cornblatt, S. F. Taylor, A. M. Auther, E. Spring, and +11 additional authors
Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder, D. McKay, D. Sookman, F. Neziroglu, S. Wilhelm, D. J. Stein, M. Kyrios, K. Matthews, and D. Veale
Neural Substrates of Inhibitory Control Deficits in 22q11.2 Deletion Syndrome, C. A. Montojo, M. Jalbrzikowski, E. Congdon, S. Domicoli, C. Chow, C. Dawson, K. H. Karlsgodt, R. M. Bilder, and C. E. Bearden
The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components, K. T. Mueser, D. L. Penn, P. Meyer-Kalos, S. R. McGurk, C. Cather, S. Saade, D. G. Robinson, N. R. Schooler, R. A. Rosenheck, J. M. Kane, and +6 additional authors
Revisiting the Discussion: Termination of Clozapine Treatment Due to Renal Failure Reply, J. Nielsen, P. Manu, J. M. Kane, and C. U. Correll
Clinical characteristics and influence of childhood trauma on the prodrome of bipolar disorder, M. N. Noto, C. Noto, A. C. Caribe, A. Miranda-Scippa, S. O. Nunes, A. C. Chaves, D. Amino, R. Grassi-Oliveira, C. U. Correll, and E. Brietzke
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways, C. O'Dushlaine, C. Betancur, S. Herms, R. Krasucki, M. Leboyer, D. H. Ledbetter, T. Lencz, A. K. Malhotra, J. W. Smoller, P. A. Holmans, and +365 additional authors
Objective identification and analysis of physiological and behavioral signs of schizophrenia, M. Osipov, Y. Behzadi, J. M. Kane, G. Petrides, and G. D. Clifford
PANSS-6: a brief rating scale for the measurement of severity in schizophrenia, S. D. Ostergaard, O. M. Lemming, O. Mors, C. U. Correll, and P. Bech
Delayed identification and diagnosis of Huntington's disease due to psychiatric symptoms, A. M. Pascu, P. Ifteni, A. Teodorescu, V. Burtea, and C. U. Correll
Severity of thought disorder predicts psychosis in persons at clinical high-risk, D. O. Perkins, C. D. Jeffries, B. A. Cornblatt, S. W. Woods, J. Addington, D. H. Mathalon, L. J. Seidman, M. T. Tsuang, E. F. Walker, T. H. McGlashan, and +4 additional authors
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives, A. M. Persico, C. Arango, J. K. Buitelaar, C. U. Correll, J. C. Glennon, P. J. Hoekstra, C. Moreno, B. Vitiello, J. Vorstman, and A. Zuddas
Prevalence of childhood obsessive-compulsive personality traits in adults with obsessive compulsive disorder versus obsessive compulsive personality disorder, A. Pinto, A. L. Greene, E. A. Storch, and H. B. Simpson
A Case of Deep Brain Stimulation for Tourette's Complicated by Twiddler's Syndrome, M. H. Pourfar, Cathy Budman, and A. Y. Mogilner
Early stages of bipolar disorder: characterization and strategies for early intervention, A. C. Rios; M. N. Noto; L. B. Rizzo; R. Mansur; F. E., Jr. Martins; R. Grassi-Oliveira; C. U. Correll; and E. Brietzke
Sudden Cardiac Death in Young Adults With Previous Hospital-Based Psychiatric Inpatient and Outpatient Treatment: A Nationwide Cohort Study From Denmark, B. Risgaard, K. Waagstein, R. Jabbari, T. H. Lynge, C. Glinge, C. Albert, C. U. Correll, S. Haunso, A. Fink-Jensen, J. Tfelt-Hansen, and +1 additional author
Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics, A. M. Rodday, S. K. Parsons, C. Mankiw, C. U. Correll, A. S. Robb, B. T. Zima, T. S. Saunders, and L. K. Leslie
Maintenance Electroconvulsive Therapy: Cost-effectiveness and Patient/Family Satisfaction, R. Rodriguez-Jimenez, A. Bagney, I. Torio, M. Caballero, P. Ruiz, F. P. Rivas-Clemente, M. A. Jimenez-Arriero, and G. Petrides
The Relationship of Common Risk Variants and Polygenic Risk for Schizophrenia to Sensorimotor Gating, P. Roussos, S. G. Giakoumaki, C. Zouraraki, J. F. Fullard, V. E. Karagiorga, E. M. Tsapakis, Z. Petraki, L. J. Siever, T. Lencz, A. Malhotra, and +2 additional authors
Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review, M. T. Samara, Y. C. Chung, B. Crespo-Facorro, H. Elkis, M. M. Leeflang, K. Hatta, I. Giegling, J. M. Kane, C. U. Correll, S. Leucht, and +11 additional authors
A variable number of tandem repeats in the 3 '-untranslated region of the dopamine transporter modulates striatal function during working memory updating across the adult age span, F. Sambataro, J. E. Podell, V. P. Murty, S. Das, B. Kolachana, T. E. Goldberg, D. R. Weinberger, and V. S. Mattay
Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia, D. K. Sarpal, D. G. Robinson, T. Lencz, M. Argyelan, T. Ikuta, K. Karlsgodt, J. Gallego, J. M. Kane, P. R. Szeszko, and A. K. Malhotra
Rivastigmine Treatment of Othello Syndrome and Post-ECT Delirium in a Patient With Parkinson's Disease, A. Scicutella
A Common Polymorphism in SCN2A Predicts General Cognitive Ability through Effects on PFC Physiology, M. A. Scult, J. W. Trampush, F. Zheng, E. D. Conley, T. Lencz, A. K. Malhotra, D. Dickinson, D. R. Weinberger, and A. R. Hariri
Neural systems mediating decision-making and response inhibition for social and nonsocial stimuli in autism, K. M. Shafritz, J. D. Bregman, T. Ikuta, and P. R. Szeszko
Patterns of clozapine and other antipsychotics prescriptions in patients with treatment-resistant schizophrenia in community mental health centers in Sao Paulo, Brazil, A. S. D. Silveira, D.M.L.V. Rocha, C. R. D. Attux, C. S. Daltio, L. A. da Silva, H. Elkis, J. M. Kane, and R. A. Bressan
Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study, B. Sneider, S. G. Pristed, C. U. Correll, and J. Nielsen
Inflammatory cytokines and anorexia nervosa: A meta-analysis of cross-sectional and longitudinal studies, M. Solmi, N. Veronese, A. Favaro, P. Santonastaso, E. Manzato, G. Sergi, and C. U. Correll
Oxidative stress and antioxidant levels in patients with anorexia nervosa: A systematic review and exploratory meta-analysis, M. Solmi, N. Veronese, E. Manzato, G. Sergi, A. Favaro, P. Santonastaso, and C. U. Correll
Impairments in Negative Facial Emotion Recognition in Chinese Schizophrenia Patients Detected With a Newly Designed Task, Y. Song, Y. T. Xiang, X. Wang, F. Zhang, J. S. Kwan, O. C. Chan, Z. Wang, G. S. Ungvari, C. U. Correll, C. Zaroff, and +2 additional authors
Lack of cardinal symptoms of meningitis in a hospitalized patient with chronic schizophrenia: lessons to be learned, R. So, T. Hirota, Y. Yamamoto, A. Hishimoto, and C. U. Correll
Neural and behavioral substrates of disorientation in mild cognitive impairment and Alzheimer's disease, A. Sousa, J. J. Gomar, and T. E. Goldberg
Recognition deficits in mice carrying mutations of genes encoding BLOC-1 subunits pallidin or dysbindin, S. Spiegel, A. Chiu, A. S. James, J. D. Jentsch, and K. H. Karlsgodt
Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial, M. Stentebjerg-Olesen, S. J. Ganocy, R. L. Findling, K. Chang, M. P. DelBello, J. M. Kane, M. Tohen, P. Jeppesen, and C. U. Correll
The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis, B. Stubbs, L. Eggermont, A. J. Mitchell, M. De Hert, C. U. Correll, A. Soundy, S. Rosenbaum, and D. Vancampfort
Decreased Pain Sensitivity Among People with Schizophrenia: A Meta-analysis of Experimental Pain Induction Studies, B. Stubbs, T. Thompson, S. Acaster, D. Vancampfort, F. Gaughran, and C. U. Correll
Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group, K. W. Suhs, C. U. Correll, C. K. Eberlein, R. Pul, H. Frieling, S. Bleich, and K. G. Kahl
The Program Director Scholar: Aspiration and Perspiration, R. F. Summers and J. Q. Young
Asenapine Once Daily Versus Twice Daily: Impact on Patient Acceptance in a Randomized, Open-Label, 14-Day Clinical Trial, X. Sun, R. Hamer, and J. McEvoy
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis, D. Vancampfort, B. Stubbs, A. J. Mitchell, M. De Hert, M. Wampers, P. B. Ward, S. Rosenbaum, and C. U. Correll
Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis, N. Veronese, G. Bano, G. Bertozzo, S. Granziera, M. Solmi, E. Manzato, G. Sergi, A. T. Cohen, and C. U. Correll
Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjects, N. Veronese, E. Manzato, S. Maggi, P. Manu, G. Zuliani, M. Wong, K. Lok, J. Kane, G. Sergi, C. U. Correll, and +29 additional authors
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores, B. J. Vilhjalmsson, J. Yang, H. K. Finucane, A. Gusev, S. Lindstrom, S. Ripke, R. Tamimi, E. Stahl, A. L. Price, T. Lencz, and +25 additional authors
Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes, A. N. Voineskos, D. Felsky, A. L. Wheeler, D. J. Rotenberg, M. Levesque, S. Patel, P. R. Szeszko, J. L. Kennedy, T. Lencz, and A. K. Malhotra
Demographic correlates of attenuated positive psychotic symptoms, R. N. Waford, A. MacDonald, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, R. Heinssen, D. O. Perkins, L. J. Seidman, S. W. Woods, T. H. McGlashan, and +8 additional authors
Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis, J. R. Webb, J. Addington, D. O. Perkins, C. E. Bearden, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, E. F. Walker, T. H. McGlashan, S. W. Woods, and +4 additional authors
QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009, Y. T. Xiang, H. F. K. Chiu, G. S. Ungvari, C. U. Correll, K. Y. C. Lai, P. Udomratn, K. Y. Chee, N. Sartorius, C. H. Tan, N. Shinfuku, and +12 additional authors
Use of electroconvulsive therapy for Asian patients with schizophrenia (2001-2009): Trends and correlates, Y. T. Xiang, G. S. Ungvari, C. U. Correll, H. F. Chiu, K. Y. Lai, K. Sim, M. K. Yong, N. Sartorius, C. H. Tan, N. Shinfuku, and +12 additional authors
Quality of Life in Older Patients With Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study, Y. T. Xiang, T. S. Wong, J. Tsoh, G. S. Ungvari, C. U. Correll, J. Sareen, K. Penner-Goeke, F. W. S. Ko, D. S. C. Hui, and H. F. K. Chiu
Applying cognitive load theory to medical education: construct and measurement challenges, John Young and J. L. Sewell